Smart jab can shrink head and neck cancer tumours within six weeks, trial finds
Triple-action therapy drug amivantamab could be given as an injection to help treat recurrent or metastatic cancers Doctors have hailed “incredibly encouraging” trial results that show a triple-action smart jab can shrink tumours in head and neck cancer patients within six weeks. Head and neck (…)
Site référencé:
The Guardian (Europe)
3566.jpg?width=140&quality=85&auto=format&fit=max&s=6b8d8aa1d243e52630ec912240d7c64f, 3566.jpg?width=460&quality=85&auto=format&fit=max&s=2d87713509e54a6825bcd7efa979683a, 3566.jpg?width=700&quality=85&auto=format&fit=max&s=0f55e3e23cd4fdddf1f92afd52d64c83
The Guardian (Europe)
Landslide win for pro-EU Turkish Cypriot candidate raises hopes for peace
19/10/2025
Verstappen cruises to victory in F1 US Grand Prix to pile pressure on McLaren
19/10/2025
MPs urged to confront royal family over Prince Andrew’s Epstein links
19/10/2025
Slot concedes Liverpool face challenge after Manchester United’s Anfield win
19/10/2025
England invite Noah Caluori to training after sparkling five-try Prem debut
19/10/2025
Dead fish found on River Thet where large stretch of white foam appeared
19/10/2025